Clinical Trial Update: Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated peripheral stem cell transplantation to prevent neutropenia in patients with relapsed or refractory non-Hodgkin lymphoma undergoing ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Northwestern University | Conditions: Lymphoma, Neutropenia | Phase 1 | Status: TERMINATED